Internal Medicine, Infectious Disease · San Antonio, TX
NPI
1922209733
Since 2007
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1200 Brooklyn Ave Ste 365
San Antonio, TX, 78212
Phone (210) 224-9616
Groups this clinician bills Medicare through
Medicare paid, 2024
$47K
1,505 services
Medicare patients, 2024
114
Average age 68
Drug cost, 2024
$923K
534 prescriptions
Company payments, 2025
$52.61
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kimberly A Moran was code 99232 (hospital e&m - subsequent), 191 times for 67 patients. In total Kimberly A Moran billed 1,505 services in 13 codes, and Medicare paid $47K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 191 | 67 | $58.88 | $11K |
| 99233 Hospital E&M - Subsequent | Facility | 161 | 61 | $89.70 | $14K |
| 99222 Hospital E&M - Initial | Facility | 92 | 86 | $97.55 | $8,975 |
| 99213 Office E&M - Established | Office | 27 | 15 | $55.26 | $1,492 |
By year: 2022 $51K for 7,648 services; 2023 $50K for 651 services; 2024 $47K for 1,505 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kimberly A Moran prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 109 prescriptions and refills. In total Kimberly A Moran wrote 534 Medicare prescriptions that cost $923K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 109 | 109 | 11 | $460K |
| Doxycycline Hyclate Generic | 32 | 80 | 11 | $2,807 |
| Fluconazole Generic | 22 | 57 | Under 11 | $1,092 |
| Juluca Dolutegravir/Rilpivirine | 21 | 21 | Under 11 | $75K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 20 | 52 | Under 11 | $290 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 17 | 17 | Under 11 | $67K |
| Azithromycin Generic | 16 | 41 | Under 11 | $191 |
| Ritonavir Generic | 16 | 16 | Under 11 | $1,010 |
| Tivicay Dolutegravir Sodium | 16 | 16 | Under 11 | $62K |
| Emtricitabine Generic | 15 | 15 | Under 11 | $6,948 |
| Isentress Hd Raltegravir Potassium | 15 | 15 | Under 11 | $28K |
| Daptomycin Generic | 14 | 14 | Under 11 | $5,533 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 14 | 14 | Under 11 | $53K |
| Complera Emtricita/Rilpivirine/Tenof Df | 14 | 14 | Under 11 | $59K |
| Ceftriaxone Ceftriaxone Sodium | 13 | 13 | Under 11 | $275 |
Brand drugs: 241 claims; generic drugs: 293 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kimberly A Moran $52.61 ($52.61 in general payments such as food, travel and fees) from 1 company. The largest payer was Gilead Sciences, Inc. with $52.61.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 2 | $52.61 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.